Conformation of gp120 determines the sensitivity of HIV-1 DH012 to the entry inhibitor IC9564. (Q47318968)

13 January 2018

title

Conformation of gp120 determines the sensitivity of HIV-1 DH012 to the entry inhibitor IC9564. (English)

1 reference

13 January 2018

author

Li Huang

2

1 reference

13 January 2018

author name string

Xiong Yuan

1

1 reference

13 January 2018

Phong Ho

3

1 reference

13 January 2018

Celia Labranche

4

1 reference

13 January 2018

Chin Ho Chen

5

1 reference

13 January 2018

language of work or name

English

0 references

publication date

1 July 2004

1 reference

13 January 2018

number of pages

6

1 reference

based on heuristic

inferred from page(s)

published in

Virology

1 reference

13 January 2018

volume

324

1 reference

13 January 2018

issue

2

1 reference

13 January 2018

page(s)

525-530

1 reference

13 January 2018

Identification of gp120 regions targeted by a highly potent neutralizing antiserum elicited in a chimpanzee inoculated with a primary human immunodeficiency virus type 1 isolate

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.009

Anti-AIDS agents--XXVII. Synthesis and anti-HIV activity of betulinic acid and dihydrobetulinic acid derivatives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.009

Stable exposure of the coreceptor-binding site in a CD4-independent HIV-1 envelope protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.009

Role of human immunodeficiency virus (HIV) type 1 envelope in the anti-HIV activity of the betulinic acid derivative IC9564

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.009

Molecular targets of anti-HIV-1 triterpenes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.009

Anti-human immunodeficiency virus activity of YK-FH312 (a betulinic acid derivative), a novel compound blocking viral maturation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.009

Loss of a single N-linked glycan allows CD4-independent human immunodeficiency virus type 1 infection by altering the position of the gp120 V1/V2 variable loops

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.009

Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.009

Sensitivity to a nonpeptidic compound (RPR103611) blocking human immunodeficiency virus type 1 Env-mediated fusion depends on sequence and accessibility of the gp41 loop region

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.009

PA-457: A potent HIV inhibitor that disrupts core condensation by targeting a late step in Gag processing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.009

Triterpene derivatives that block entry of human immunodeficiency virus type 1 into cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.009

Genetic subtypes, humoral immunity, and human immunodeficiency virus type 1 vaccine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.009

gp120: Biologic aspects of structural features

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.009

Generation of a neutralization-resistant variant of HIV-1 is due to selection for a point mutation in the envelope gene.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.009

A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.009

Betulinic acid derivatives: a new class of specific inhibitors of human immunodeficiency virus type 1 entry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.009

Anti-AIDS agents 49. Synthesis, anti-HIV, and anti-fusion activities of IC9564 analogues based on betulinic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.009

Small-molecule inhibition of human immunodeficiency virus type 1 replication by specific targeting of the final step of virion maturation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.009

The role of the third beta strand in gp120 conformation and neutralization sensitivity of the HIV-1 primary isolate DH012

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.009

Neutralization epitopes of the HIV-1 primary isolate DH012

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.009

Human immunodeficiency virus type 1 coreceptors participate in postentry stages in the virus replication cycle and function in simian immunodeficiency virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.009

inferred from DOI database lookup

7 January 2021

based on heuristic

Resistance to a drug blocking human immunodeficiency virus type 1 entry (RPR103611) is conferred by mutations in gp41

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.009

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VIROL.2004.04.009

1 reference

13 January 2018

1 reference

13 January 2018